IPO

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

The biotech firm secures major funding to push its promising head and neck cancer drug, ficerafusp alfa, toward regulatory approval and commercial launch.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

The Raine Group hires Credit Suisse veteran Anthony Kontoleon, signaling a major push to dominate TMT advisory ahead of an anticipated tech boom.

Medtronic's diabetes arm hits the road for its IPO, seeking to raise up to $784M in a major test of investor appetite for specialized medtech firms.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

With a promise of cellular renewal via exosomes, (plated) Skin Science is leading a biotech revolution. But can it navigate the hype and regulatory hurdles?

Leaving the volatile crypto world behind, Cipher Digital is raising billions to build massive data centers for tech giants like AWS and Google.

Tech giant OpenTable is shaking up London's dining scene with new awards, using its vast data, expert panels, and diner votes to crown the city's best.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

Maiden drilling at West Santa Fe reveals significant near-surface gold, sparking speculation of a low-cost, open-pit mine in the prolific Walker Lane.

With its Moda-flx system cleared by the FDA, Diality hires M&A expert Peter Donato to navigate the path to commercialization in the $92B dialysis market.

Apellis Pharmaceuticals reports its first profitable year on strong SYFOVRE and EMPAVELI sales, but faces pressure to maintain momentum amid competition.

Fintech firm Chronograph hires a private credit expert from Blue Owl and partners with AI leader Anthropic to revolutionize portfolio monitoring.

The powertrain giant crushed market expectations with a 29% revenue surge in 2025, fueled by heavy-duty engines, while eyeing a global and green future.

US consumers are sitting on $83B in unused tech. New research shows why brands failing to offer good trade-in programs are losing revenue and loyalty.

Drilling at the Tesorito deposit has intersected a potential high-grade feeder zone, suggesting a much larger and richer system than previously modeled.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

Fintech unicorn Clear Street pulls its much-anticipated IPO, a move that highlights a tough market forcing many tech firms to reconsider public debuts.

The hospitality REIT posts a record year, fueled by strong group bookings at its Gaylord hotels and an aggressive expansion into live entertainment markets.